EU Panel Recommends Marketing Authorization For Multiple-sclerosis ...
Trading Markets - Los Angeles,CA,USA
... or CHMP, the scientific committee of the European Medicines Agency, issued a positive opinion recommending marketing authorization for Tysabri, a treatment for ...

MS drug Tysabri closer to EU launch
United Press International - USA
CAMBRIDGE, Mass., April 28 (UPI) -- Biogen Idec and Elan said their multiple-sclerosis drug Tysabri has been recommended for approval in Europe. ...

Elan Corp. Is Trading Higher On Tysabri News
Trading Markets - Los Angeles,CA,USA
... Friday morning that the Committee for Medicinal Products for Human Use issued a positive opinion recommending marketing authorization for TYSABRI as a ...

CHMP Issues Positive Opinion for Tysabri (Natalizumab) as a ...
DG News - USA
... the scientific committee of the European Medicines Agency (EMEA), issued a positive opinion recommending marketing authorization for Tysabri® (natalizumab) as ...

Elan's Tysabri drug recommended by EU committee
MarketWatch - USA
... news that the scientific committee of the European Medicines Agency had recommended the return to market of its key drug, multiple sclerosis treatment Tysabri. ...

European Medicines Agency unit approves return of Elan's Tysabri ...
FinFacts Ireland - Ireland
... The Committee recommended that Tysabri be used as single disease modifying therapy either in patients with highly active relapsing-remitting MS who have failed ...